BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11541511)

  • 21. A comparison of pharmacologic and spontaneous baroreflex methods in aging and hypertension.
    Milic M; Sun P; Liu F; Fainman C; Dimsdale J; Mills PJ; Ziegler MG
    J Hypertens; 2009 Jun; 27(6):1243-51. PubMed ID: 19365284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal heart rate and blood pressure responses to baroreflex stimulation in multiple sclerosis patients.
    Sanya EO; Tutaj M; Brown CM; Goel N; Neundörfer B; Hilz MJ
    Clin Auton Res; 2005 Jun; 15(3):213-8. PubMed ID: 15944871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Limited utility of the phenylephrine-nitroprusside sigmoid curve method of measuring baroreflex function after myocardial infarction.
    Leitch JW; Newling R; Nyman E; Cox K; Dear K
    J Cardiovasc Risk; 1997 Jun; 4(3):179-84. PubMed ID: 9475672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide and cardiac parasympathetic control in human heart failure.
    Chowdhary S; Ng GA; Nuttall SL; Coote JH; Ross HF; Townend JN
    Clin Sci (Lond); 2002 Apr; 102(4):397-402. PubMed ID: 11914101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of aging on cardiac baroreflex sensitivity determined non-invasively by power spectral analysis.
    Piccirillo G; Cacciafesta M; Viola E; Santagada E; Nocco M; Lionetti M; Bucca C; Moisè A; Tarantini S; Marigliano V
    Clin Sci (Lond); 2001 Mar; 100(3):267-74. PubMed ID: 11222112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baroreflex modulation of blood pressure and heart rate variabilities in rats: assessment by spectral analysis.
    Cerutti C; Barres C; Paultre C
    Am J Physiol; 1994 May; 266(5 Pt 2):H1993-2000. PubMed ID: 8203598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the prognostic values of invasive and noninvasive assessments of baroreflex sensitivity in heart failure.
    La Rovere MT; Maestri R; Robbi E; Caporotondi A; Guazzotti G; Febo O; Pinna GD
    J Hypertens; 2011 Aug; 29(8):1546-52. PubMed ID: 21666492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spontaneous baroreflex by sequence and power spectral methods in humans.
    Hughson RL; Quintin L; Annat G; Yamamoto Y; Gharib C
    Clin Physiol; 1993 Nov; 13(6):663-76. PubMed ID: 8119060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A noninvasive measure of baroreflex sensitivity without blood pressure measurement.
    Davies LC; Colhoun H; Coats AJ; Piepoli M; Francis DP
    Am Heart J; 2002 Mar; 143(3):441-7. PubMed ID: 11868049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of baroreflex sensitivity determined by cross-spectral analysis at respiratory and 0.1 Hz frequencies in man.
    Bothová P; Honzíková N; Fiser B; Závodná E; Nováková Z; Kalina D; Honzíková K; Lábrová R
    Physiol Res; 2010; 59 Suppl 1():S103-S111. PubMed ID: 20626214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring directionality in spontaneous heart period and systolic pressure variability interactions in humans: implications in the evaluation of baroreflex gain.
    Nollo G; Faes L; Porta A; Antolini R; Ravelli F
    Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1777-85. PubMed ID: 15604132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical value of baroreflex sensitivity determined by spectral analysis in risk stratification after myocardial infarction.
    Honzikova N; Fiser B; Semrad B
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1965-7. PubMed ID: 11139968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oesophageal acid stimulation in humans: does it alter baroreflex function?
    Zöllei E; Paprika D; Wittmann T; Rosztóczy A; Róka R; Gingl Z; Rudas L
    Acta Physiol Hung; 2003; 90(2):109-14. PubMed ID: 12903909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noninvasive assessment of baroreflex control in borderline hypertension. Comparison with the phenylephrine method.
    Watkins LL; Grossman P; Sherwood A
    Hypertension; 1996 Aug; 28(2):238-43. PubMed ID: 8707388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baroreflex sensitivity as a new marker for risk stratification.
    La Rovere MT
    Z Kardiol; 2000; 89 Suppl 3():44-50. PubMed ID: 10810784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose atropine amplifies cardiac vagal modulation and increases dynamic baroreflex function in humans.
    Cho SK; Hwang GS; Kim YK; Huh IY; Hahm KD; Han SM
    Auton Neurosci; 2005 Mar; 118(1-2):108-15. PubMed ID: 15795184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential change in cardiac baroreflex sensitivity estimated by sequence and spectral analysis during etomidate anesthesia.
    Wang YP; Shih RL; Huang CL; Huang HH; Tsai SK
    Clin Auton Res; 2000 Jun; 10(3):117-21. PubMed ID: 10954069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of phenylephrine bolus and infusion methods in baroreflex measurements.
    Sullebarger JT; Liang CS; Woolf PD; Willick AE; Richeson JF
    J Appl Physiol (1985); 1990 Sep; 69(3):962-7. PubMed ID: 2246183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Applicability of new techniques in the assessment of arterial baroreflex sensitivity in the elderly: a comparison with established pharmacological methods.
    James MA; Panerai RB; Potter JF
    Clin Sci (Lond); 1998 Mar; 94(3):245-53. PubMed ID: 9616258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-blocker effects on respiratory sinus arrhythmia and baroreflex gain in normal subjects.
    Pitzalis MV; Mastropasqua F; Massari F; Passantino A; Totaro P; Forleo C; Rizzon P
    Chest; 1998 Jul; 114(1):185-91. PubMed ID: 9674468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.